These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 23241890)
1. Resolvin E1 and chemokine-like receptor 1 mediate bone preservation. Gao L; Faibish D; Fredman G; Herrera BS; Chiang N; Serhan CN; Van Dyke TE; Gyurko R J Immunol; 2013 Jan; 190(2):689-94. PubMed ID: 23241890 [TBL] [Abstract][Full Text] [Related]
2. Resolvin E1 Promotes Bone Preservation Under Inflammatory Conditions. El Kholy K; Freire M; Chen T; Van Dyke TE Front Immunol; 2018; 9():1300. PubMed ID: 29946319 [TBL] [Abstract][Full Text] [Related]
3. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. Arita M; Ohira T; Sun YP; Elangovan S; Chiang N; Serhan CN J Immunol; 2007 Mar; 178(6):3912-7. PubMed ID: 17339491 [TBL] [Abstract][Full Text] [Related]
4. The role of polyunsaturated ω-3 fatty acid eicosapentaenoic acid-derived resolvin E1 (RvE1) in bone preservation. Gyurko R; Van Dyke TE Crit Rev Immunol; 2014; 34(4):347-57. PubMed ID: 24941160 [TBL] [Abstract][Full Text] [Related]
5. Differential effects of resolvin D1 and resolvin E1 on cementoblast function. Bozkurt SB; Hakki SS; Kantarci A J Periodontol; 2023 Nov; 94(11):1351-1362. PubMed ID: 37322861 [TBL] [Abstract][Full Text] [Related]
6. An endogenous regulator of inflammation, resolvin E1, modulates osteoclast differentiation and bone resorption. Herrera BS; Ohira T; Gao L; Omori K; Yang R; Zhu M; Muscara MN; Serhan CN; Van Dyke TE; Gyurko R Br J Pharmacol; 2008 Dec; 155(8):1214-23. PubMed ID: 18806821 [TBL] [Abstract][Full Text] [Related]
14. The impact of Resolvin E1 on bone regeneration in critical-sized calvarial defects of rat model-A gene expression and micro-CT analysis. Alrumaih S; Alshibani N; Alssum L; Alshehri FA; AlMayrifi MA; AlMayouf M; Alrahlah A; Bautista LSJ J Periodontal Res; 2024 Feb; 59(1):195-203. PubMed ID: 37947141 [TBL] [Abstract][Full Text] [Related]
15. Resolvin E1 metabolome in local inactivation during inflammation-resolution. Hong S; Porter TF; Lu Y; Oh SF; Pillai PS; Serhan CN J Immunol; 2008 Mar; 180(5):3512-9. PubMed ID: 18292578 [TBL] [Abstract][Full Text] [Related]
16. Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets. Dona M; Fredman G; Schwab JM; Chiang N; Arita M; Goodarzi A; Cheng G; von Andrian UH; Serhan CN Blood; 2008 Aug; 112(3):848-55. PubMed ID: 18480426 [TBL] [Abstract][Full Text] [Related]
17. Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions. Arita M; Oh SF; Chonan T; Hong S; Elangovan S; Sun YP; Uddin J; Petasis NA; Serhan CN J Biol Chem; 2006 Aug; 281(32):22847-54. PubMed ID: 16757471 [TBL] [Abstract][Full Text] [Related]
18. Resolvin E1/ChemR23 Protects Against Hypertension and Vascular Remodeling in Angiotensin II-Induced Hypertensive Mice. Zhang J; Yin Z; Xu Y; Wei C; Peng S; Zhao M; Liu J; Xu S; Pan W; Zheng Z; Liu S; Ye J; Qin JJ; Wan J; Wang M Hypertension; 2023 Dec; 80(12):2650-2664. PubMed ID: 37800344 [TBL] [Abstract][Full Text] [Related]